Fortis Healthcare Limited — Important, 07-02-2025: Financial Result Updates

Fortis Healthcare Limited reported solid financial results for the quarter and half-year ended December 31, 2024, with consolidated revenue from operations reaching ₹1,928.26 crores, marking a 14.71% year-on-year growth compared to ₹1,679.68 crores in the same quarter last year. The growth can be attributed to higher patient inflow and robust performance across healthcare segments.

Net profit for the quarter stood at ₹254.30 crores, significantly up from ₹134.23 crores in the previous year, reflecting a remarkable year-on-year increase of 89.45%. The Earnings Per Share (EPS) for the quarter increased to ₹3.28, compared to ₹1.78 last year, driven by operational efficiency and improved demand.

Operational costs rose by 11.88%, attributed mainly to increased medical consumable purchases and staff expenses, reflecting the company's focus on expanding service capacity. However, control over costs remains a focus area, especially with rising professional charges and finance costs that also contributed to the overall expenditure.

The balance sheet reflects robust health, with total assets amounting to ₹1,488.21 crores against total liabilities of ₹589.83 crores, resulting in a solid debt-to-equity ratio of 0.29. The strong cash flow position promises continued investment in growth initiatives and potential shareholder returns.

As for the outlook, Fortis appears poised for further growth through strategic initiatives, including the expansion of services and ongoing investments in technology. Market sentiment remains positive, offering opportunities for continued revenue growth.

Given the financial performance and strategic positioning, considering the growth prospects and ongoing operational efficiencies, Fortis appears a suitable candidate for investors seeking growth in the healthcare sector.